This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Key Opinion

Expert perspectives on assay reproducibility in family medicine

  • Early screening programs
  • Data normalization
  • Biomarker-guided therapy
  • Combination therapy

Date Published:

Abstract

According to consensus recommendations, pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. Recent studies suggest that standardized reporting improves comparability between centers, although confirmatory data are still limited. When protocols are compared, early intervention correlates with better long-term outcomes, which has direct implications for daily practice.

According to consensus recommendations, pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. In routine practice, real-world registries complement randomized trial evidence, which has direct implications for daily practice. Recent studies suggest that standardized reporting improves comparability between centers, as discussed in the accompanying commentary. According to consensus recommendations, patient selection criteria deserve closer scrutiny, and this trend is expected to continue. When protocols are compared, patient selection criteria deserve closer scrutiny, particularly in resource-constrained settings.

Emerging evidence indicates that integrating quantitative measures reduces subjective bias, particularly in resource-constrained settings. When protocols are compared, training and accreditation are decisive for reproducibility, although confirmatory data are still limited. In multidisciplinary settings, early intervention correlates with better long-term outcomes, with meaningful differences between subgroups. Recent studies suggest that digital tooling shortens time-to-decision considerably, and this trend is expected to continue.

Recent studies suggest that early intervention correlates with better long-term outcomes, a finding echoed by several independent groups. According to consensus recommendations, training and accreditation are decisive for reproducibility, as discussed in the accompanying commentary. Emerging evidence indicates that pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups. Recent studies suggest that early intervention correlates with better long-term outcomes, a finding echoed by several independent groups.

In routine practice, integrating quantitative measures reduces subjective bias, which has direct implications for daily practice. In multidisciplinary settings, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. Emerging evidence indicates that real-world registries complement randomized trial evidence, particularly in resource-constrained settings. When protocols are compared, training and accreditation are decisive for reproducibility, which has direct implications for daily practice.

References

  1. Haddad et al. First-line treatment selection. J Family medicine Res. 2023;15(2):957-1036.
  2. Silva et al. High-throughput screening. J Family medicine Res. 2026;32(8):907-1072.
  3. Okafor et al. Assay reproducibility. J Family medicine Res. 2026;38(4):651-1082.